227 related articles for article (PubMed ID: 2966200)
1. Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.
Sykes M; Eisenthal A; Sachs DH
J Immunol; 1988 May; 140(9):2903-11. PubMed ID: 2966200
[TBL] [Abstract][Full Text] [Related]
2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
3. Suppressive activity in recipients of non-T cell-depleted allogeneic bone marrow transplants: role of T cell-depleted syngeneic marrow.
Sykes M
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():30-3. PubMed ID: 2534057
[TBL] [Abstract][Full Text] [Related]
4. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
Azuma E; Yamamoto H; Kaplan J
J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
[TBL] [Abstract][Full Text] [Related]
5. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; BĂ©langer R; Gyger M
Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
[TBL] [Abstract][Full Text] [Related]
6. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.
Sykes M; Bukhari Z; Sachs DH
Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325
[TBL] [Abstract][Full Text] [Related]
8. [A study on the veto cells from H-2 recombinant mice and allogeneic bone marrow chimeric mice].
Ogasawara M
Hokkaido Igaku Zasshi; 1986 Nov; 61(6):883-91. PubMed ID: 2951312
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
Ogasawara M; Iwabuchi K; Good RA; Onoe K
J Immunol; 1988 Nov; 141(10):3306-12. PubMed ID: 2972771
[TBL] [Abstract][Full Text] [Related]
10. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
Sykes M; Sheard M; Sachs DH
J Immunol; 1988 Oct; 141(7):2282-8. PubMed ID: 3049804
[TBL] [Abstract][Full Text] [Related]
11. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
Maier T; Holda JH; Claman HN
J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
[TBL] [Abstract][Full Text] [Related]
12. The recovery of resistance to alloengraftment following lethal irradiation and administration of T cell-depleted syngeneic bone marrow.
Chester CH; Sykes M; Sachs DH
Bone Marrow Transplant; 1989 Mar; 4(2):195-200. PubMed ID: 2650790
[TBL] [Abstract][Full Text] [Related]
13. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
Thiele DL; Calomeni JA; Lipsky PE
J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
[TBL] [Abstract][Full Text] [Related]
14. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
Palathumpat V; Dejbakhsh-Jones S; Holm B; Strober S
J Immunol; 1992 Aug; 149(3):808-17. PubMed ID: 1386094
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.
Hiruma K; Gress RE
J Immunol; 1992 Sep; 149(5):1539-47. PubMed ID: 1387142
[TBL] [Abstract][Full Text] [Related]
16. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
Taniguchi K; Gondo H; Nomoto K
J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
[TBL] [Abstract][Full Text] [Related]
17. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
Sykes M; Sharabi Y; Sachs DH
Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
[TBL] [Abstract][Full Text] [Related]
18. Suppressor T cells in allogeneic bone marrow chimeras.
Leshem B; Lebendiker Z; Weiss L; Slavin S; Kedar E
Bone Marrow Transplant; 1987 Aug; 2(2):123-32. PubMed ID: 2901877
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in the rat. V. Lymphoid cell subclasses in the target organs during acute graft-versus-host disease.
Renkonen R
Transplantation; 1986 Jun; 41(6):704-8. PubMed ID: 2940737
[TBL] [Abstract][Full Text] [Related]
20. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]